SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)

COVID-19 antigen rapid test kit – Saliva and swab samples all in one!

Detection objects	SARS-CoV-2 antigen
Methodology	Colloidal Gold Method
Sample type	Saliva, Nasopharyngeal Swab, Oropharyngeal Swab
Specifications	1 test/kit, 20 tests/kit
Product code	CoVSLFA-01, CoVSLFA-20

Send email to us

Product Detail

Product Tags

Product Introduction

Saliva and swab samples all in one!

Virusee® SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) is a colloidal gold method based on the principle of the double antibody-sandwich technique. It is designed to detect nucleocapsid protein antigen from the SARS-CoV-2 in saliva, nasopharyngeal swab and oropharyngeal swab, from patients who are suspected of SARS-CoV-2 infection. 1 test or 20 tests/kit available, with most tools provided in the kit. The product is included in Chinese white list, has passed evaluation of German BfArM and PEI, and is now in the EU common list.

Characteristics

Name	SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)
Method	Colloidal Gold
Sample type	Nasopharyngeal swab, Oropharyngeal swab, Saliva
Specification	1 test/kit, 20 tests/kit
Detection time	15 min
Detection objects	COVID-19
Stability	Stable for 18 months at 2-30°C
Sensitivity	96.23%
Specificity	99.26%

Advantages

Choose the solution that suits you best!
Samples applicable: Saliva, nasopharyngeal swab, oropharyngeal swab
Specifications: VSLFA-01: 1 test/kit. VSLFA-20: 20 tests/kit
User-friendly design
Obtain result within 15 min
Visually reading result, no need for calculation or instrument, easy to interpret
Easy and convenient, minimum manual operation

Economic and low risk
Product can be transported and stored at room temperature, reducing costs
Testing saliva or swab samples, less invasive, reducing the risk of sampling process
Included in China white list
Passed the evaluation of German BfArM and PEI
Listed in EU common list

What is COVID-19?

The novel coronaviruses (SARS-CoV-2) belong to the β-genus. COVID-19 is an acute respiratory infections disease. People are generally susceptible. Currently, the patients infected by the novel coronaviruses are the main source of infection, asymptomatic infected people can also be one. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.